Literature DB >> 26887380

The Brain NO Levels and NOS Activities Ascended in the Early and Middle Stages and Descended in the Terminal Stage in Scrapie-Infected Animal Models.

Li-Na Chen1, Jing Sun1, Xiao-Dong Yang1, Kang Xiao1, Yan Lv1, Bao-Yun Zhang1, Wei Zhou1, Cao Chen1, Chen Gao1, Qi Shi2, Xiao-Ping Dong3,4.   

Abstract

The infections of prion agents may cause progressive and fatal neurodegenerative diseases in humans and a serial of animal species. Previous studies have proposed that the levels of nitric oxide (NO) and nitric oxide synthase (NOS) in the brains of some neurodegeneration diseases changed, while S-nitrosylation (SNO) of many brain proteins altered in prion diseases. To elucidate the potential changes of brain NO levels during prion infection, the NO levels and NOS activities in the brain tissues of three scrapie experimental rodents were measured, including scrapie agent 263 K-infected hamsters and 139A- and ME7-infected mice. Both NO levels and NOS activities, including total NOS (TNOS) and inducible NOS (iNOS), were increased at the terminal stages of scrapie-infected animals. Assays of the brain samples collected at different time points during scrapie infection showed that the NO levels and NOS activities started to increase at early stage, reached to the peak in the middle stage, and dropped down at late stage. Western blots for brain iNOS revealed increased firstly and decreased late, especially in the brains of 139A- and ME7-infected mice. In line with those alterations, the levels of the SNO forms of several selected brain proteins such as aquaporin-1 (AQP1), calcium/calmodulin-dependent protein kinase II (CaMKII), neurogranin, and opalin, underwent similar changing trends, while their total protein levels did not change obviously during scrapie infection. Our data here for the first time illustrate the changing profile of brain NO and NOS during prion infection. Time-dependent alterations of brain NO level and the associated protein S-nitrosylation process may contribute greatly to the neuropathological damage in prion diseases.

Entities:  

Keywords:  Nitric oxide; Nitric oxide synthase; Prion; S-nitrosylation; Scrapie

Mesh:

Substances:

Year:  2016        PMID: 26887380     DOI: 10.1007/s12035-016-9755-z

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  61 in total

1.  Nitric oxide synthase neurons in different areas of normal aged and Alzheimer's brains.

Authors:  D T Yew; H W Wong; W P Li; H W Lai; W H Yu
Journal:  Neuroscience       Date:  1999-03       Impact factor: 3.590

Review 2.  Microglia and prion disease: a review.

Authors:  D R Brown; H A Kretzschmar
Journal:  Histol Histopathol       Date:  1997-07       Impact factor: 2.303

3.  Comparison of NADPH diaphorase activity in the brains of hamsters infected with scrapie strains 139H or 263K or with normal hamster brain homogenate.

Authors:  X Ye; H C Meeker; A C Scallet; R I Carp
Journal:  Histol Histopathol       Date:  2001-10       Impact factor: 2.303

4.  Expression of the inducible form of nitric oxide synthase by reactive astrocytes after transient global ischemia.

Authors:  M Endoh; K Maiese; J Wagner
Journal:  Brain Res       Date:  1994-07-18       Impact factor: 3.252

Review 5.  Nitric oxide and synaptic function.

Authors:  E M Schuman; D V Madison
Journal:  Annu Rev Neurosci       Date:  1994       Impact factor: 12.449

Review 6.  The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases.

Authors:  J B Schulz; R T Matthews; T Klockgether; J Dichgans; M F Beal
Journal:  Mol Cell Biochem       Date:  1997-09       Impact factor: 3.396

7.  Nomega-nitro-L-arginine, a nitric oxide synthase inhibitor, antagonizes quinolinic acid-induced neurotoxicity and oxidative stress in rat striatal slices.

Authors:  D Santamaría; V Espinoza-González; C Ríos; A Santamaría
Journal:  Neurochem Res       Date:  1999-07       Impact factor: 3.996

Review 8.  Aberrant protein s-nitrosylation in neurodegenerative diseases.

Authors:  Tomohiro Nakamura; Shichun Tu; Mohd Waseem Akhtar; Carmen R Sunico; Shu-Ichi Okamoto; Stuart A Lipton
Journal:  Neuron       Date:  2013-05-22       Impact factor: 17.173

9.  Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase.

Authors:  Z Huang; P L Huang; N Panahian; T Dalkara; M C Fishman; M A Moskowitz
Journal:  Science       Date:  1994-09-23       Impact factor: 47.728

Review 10.  An overview of human prion diseases.

Authors:  Muhammad Imran; Saqib Mahmood
Journal:  Virol J       Date:  2011-12-24       Impact factor: 4.099

View more
  8 in total

1.  Aberrant Alterations of Mitochondrial Factors Drp1 and Opa1 in the Brains of Scrapie Experiment Rodents.

Authors:  Xiao -Dong Yang; Qi Shi; Jing Sun; Yan Lv; Yue Ma; Cao Chen; Kang Xiao; Wei Zhou; Xiao-Ping Dong
Journal:  J Mol Neurosci       Date:  2016-12-06       Impact factor: 3.444

2.  Prions Strongly Reduce NMDA Receptor S-Nitrosylation Levels at Pre-symptomatic and Terminal Stages of Prion Diseases.

Authors:  Elisa Meneghetti; Lisa Gasperini; Tommaso Virgilio; Fabio Moda; Fabrizio Tagliavini; Federico Benetti; Giuseppe Legname
Journal:  Mol Neurobiol       Date:  2019-02-01       Impact factor: 5.590

Review 3.  Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2016       Impact factor: 1.990

4.  Mapping Molecular Networks within Clitoria ternatea Linn. against LPS-Induced Neuroinflammation in Microglial Cells, with Molecular Docking and In Vivo Toxicity Assessment in Zebrafish.

Authors:  Nurul Farah Adni Mat Zian; Puspanjali Swain; Siti Munirah Mohd Faudzi; Norzalina Zakaria; Wan Norhamidah Wan Ibrahim; Noraini Abu Bakar; Khozirah Shaari; Johnson Stanslas; Tae-Ik Choi; Cheol-Hee Kim
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-12

5.  Aberrant alterations of the expressions and S-nitrosylation of calmodulin and the downstream factors in the brains of the rodents during scrapie infection.

Authors:  Ren-Qing Zhang; Cao Chen; Li-Jie Xiao; Jing Sun; Yue Ma; Xiao-Dong Yang; Xiao-Feng Xu; Kang Xiao; Qi Shi; Zhi-Bao Chen; Xiao-Ping Dong
Journal:  Prion       Date:  2017-09-03       Impact factor: 3.931

6.  The effects of S-nitrosylation-induced PPARγ/SFRP5 pathway inhibition on the conversion of non-alcoholic fatty liver to non-alcoholic steatohepatitis.

Authors:  Hongyun Wang; Fengxia Li; Jing Feng; Junping Wang; Xiaobing Liu
Journal:  Ann Transl Med       Date:  2021-04

7.  Synergistic Neuroprotective Effects of Two Herbal Ingredients via CREB-Dependent Pathway.

Authors:  Xu Liu; Dongxiao Wang; Runqing Zhao; Xianzhe Dong; Yuan Hu; Ping Liu
Journal:  Front Pharmacol       Date:  2016-09-27       Impact factor: 5.810

8.  Inflammatory response of microglia to prions is controlled by sialylation of PrPSc.

Authors:  Saurabh Srivastava; Elizaveta Katorcha; Natallia Makarava; James P Barrett; David J Loane; Ilia V Baskakov
Journal:  Sci Rep       Date:  2018-07-27       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.